Investor mix
11 investors on record; lead investors include Ventures West, Delphi Ventures, TPG, H.I.G. Capital; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Private equity | 2 | 18% |
| Other / undisclosed | 3 | 27% |
Humanized monoclonal antibody based therapeutics for migraine and inflammatory diseases
11 investors on record; lead investors include Ventures West, Delphi Ventures, TPG, H.I.G. Capital; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Private equity | 2 | 18% |
| Other / undisclosed | 3 | 27% |